Blogs About
Affordability & Adherence
Insights on Omnichannel, AI and Next-Best Action in HCP Engagement
The phrases “omnichannel,” “artificial intelligence” and “next-best action” have become ubiquitous in conversations around how to overcome the challenges of reaching HCPs...
Bridging the Health Literacy Gap: Improve HCP and Patient Conversations
EHR Workflow Insights from Our Patient Access and Adherence Webinar
With Specialist HCP Engagement, the Devil is in the Details
Omnichannel marketing and artificial intelligence (AI) have made targeting clinical audiences easier and more precise. And yet, in the life sciences, we still tend to engage...
Insulin Price Drops – Enough for Diabetes Patients to Manage Costs?
Diabetes continues to plague the healthcare industry, maintaining its status as one of the top public health issues in terms of clinical outcomes and cost. The American...
The Power of an Omnichannel Network: Insights from HLTH
During my recent session at HLTH, I was given the opportunity to speak on the importance of a strong omnichannel strategy and how it can improve HCP engagement.
Insights from HLTH: Promoting Medication Affordability with AI and RWD
During my recent session at HLTH, I had the great opportunity to share a case study on how AI and real world data (RWD) increased medication affordability for patients by...
Secrets of the Data Ninjas: Takeaways from Digital Pharma East
Real-World Data (RWD) has become an essential element of pharmaceutical marketing, but as an industry, we are far from utilizing its full potential. During my recent session...
Hub and Specialty Pharmacy Models West Takeaways: Overcoming Prior Authorization Hurdles with Technology
Overcoming Disadvantaged Access Positions with Digital Tools at the Point-of-Care
In almost every therapy area, utilization management, prior authorizations, and step therapy...
Increased Osteoarthritis Brand Awareness and Prescribing Through Copay Promotion
There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of...
Addressing Medication Affordability in Vulnerable Patients During COVID-19
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...